We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$73.4B
AUM Growth
+$3.33B
Cap. Flow
-$654M
Cap. Flow %
-0.89%
Top 10 Hldgs %
10.29%
Holding
4,930
New
701
Increased
1,499
Reduced
1,475
Closed
797

Sector Composition

Rank Sector Weight
1 Energy 8.28%
2 Technology 7.86%
3 Consumer Discretionary 7.78%
4 Communication Services 7.32%
5 Healthcare 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDMO
4076
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$54K ﹤0.01%
+4,100
New +$51.7K
ALBO
4077
DELISTED
Albireo Pharma Inc
ALBO
$54K ﹤0.01%
830
-541
-39% -$37.6K
OMEX icon
4078
Odyssey Marine Exploration
OMEX
$41.5M
$49K ﹤0.01%
+2,448
New +$52.6K
HNSN
4079
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$47K ﹤0.01%
3,619
+1,138
+46% +$19.8K
ATLC icon
4080
Atlanticus Holdings
ATLC
$1.58B
$45K ﹤0.01%
16,155
ACLS icon
4081
Axcelis
ACLS
$3.94B
$44K ﹤0.01%
5,457
-1,735
-24% -$12.9K
NNVC icon
4082
NanoViricides
NNVC
$35.4M
$44K ﹤0.01%
+523
New +$37.1K
XXII
4083
22nd Century Group
XXII
$1.43M
0
ENZN
4084
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$41K ﹤0.01%
39,311
ACGN
4085
DELISTED
Aceragen Inc
ACGN
$38K ﹤0.01%
+97
New +$40K
RIOM
4086
DELISTED
RIO ALTO MNG LTD NEW COM SHS (CANADA)
RIOM
$38K ﹤0.01%
+16,200
New +$31.9K
CERE
4087
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$37K ﹤0.01%
6,961
+2,200
+46% +$11.5K
GSS
4088
DELISTED
Golden Star Resources Ltd.
GSS
$36K ﹤0.01%
12,175
-258,532
-96% -$742K
CACH
4089
DELISTED
CACHE INC (DE)
CACH
$36K ﹤0.01%
22,400
LFVN icon
4090
LifeVantage
LFVN
$80.4M
$35K ﹤0.01%
3,464
+1,200
+53% +$11.4K
UEC icon
4091
Uranium Energy
UEC
$4.9B
$34K ﹤0.01%
21,978
-161,282
-88% -$228K
GMO
4092
DELISTED
General Moly, Inc.
GMO
$34K ﹤0.01%
29,900
STAB
4093
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$32K ﹤0.01%
3,352
RCPI
4094
DELISTED
ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
$31K ﹤0.01%
+2,071
New +$35.9K
EGLE
4095
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$31K ﹤0.01%
+4
New +$34.8K
KBIO
4096
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$30K ﹤0.01%
+1,647
New +$28.2K
PRKR
4097
DELISTED
Parkervision Inc
PRKR
$26K ﹤0.01%
1,738
-4,972
-74% -$222K
FCEL icon
4098
FuelCell Energy
FCEL
$1.72B
$25K ﹤0.01%
2
-8
-80% -$79.2K
WTSL
4099
DELISTED
WET SEAL INC CL-A
WTSL
$23K ﹤0.01%
24,941
-9,400
-27% -$9.52K
NAVB
4100
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$16K ﹤0.01%
+552
New +$17.9K

Similar funds

D.E. Shaw & Co's Q2 2014 Portfolio in Review

As of Q2 2014, D.E. Shaw & Co held 4,930 positions worth $73.4B, up 4.8% from $70.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

D.E. Shaw & Co's Q2 2014 filing shows 701 new, 1,499 increased, 1,475 reduced and 797 closed positions. Its largest new stake was Navient: 11,559,516 shares worth $205M. The largest sale was Meta Platforms (Facebook), an estimated $460M.

By sector, the portfolio is most concentrated in Energy at 8.3% of assets, up from 7% a quarter earlier, followed by Technology and Consumer Discretionary.

  • D.E. Shaw & Co's largest Q2 2014 buy was Navient: 11,559,516 shares worth $205M.
  • D.E. Shaw & Co added most to Apple in Q2 2014, an estimated $402M increase.
  • D.E. Shaw & Co's biggest Q2 2014 reduction was Meta Platforms (Facebook), cutting an estimated $460M.
  • D.E. Shaw & Co fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $129M.
  • D.E. Shaw & Co's ten largest holdings make up 10% of its $73.4B portfolio in Q2 2014.
  • D.E. Shaw & Co opened 701 new positions and closed 797 in Q2 2014.
  • D.E. Shaw & Co's portfolio value rose 4.8% quarter-over-quarter to $73.4B.

Based on D.E. Shaw & Co's 13F filing for Q2 2014, filed 14 Aug 2014.